Nutrition economic evaluation of a probiotic in the prevention of antibiotic-associated diarrhea

INTRODUCTION: Antibiotic-associated diarrhea (AAD) is common and frequently more severe in hospitalized elderly adults. It can lead to increased use of healthcare resources. We estimated the cost-effectiveness of a fermented milk (FM) with probiotic in preventing AAD and in particular Clostridium di...

Full description

Bibliographic Details
Main Authors: Lenoir-Wijnkoop, I, Nuijten, M, Craig, J, Butler, C
Format: Journal article
Language:English
Published: Frontiers Media 2014
_version_ 1797074503989198848
author Lenoir-Wijnkoop, I
Nuijten, M
Craig, J
Butler, C
author_facet Lenoir-Wijnkoop, I
Nuijten, M
Craig, J
Butler, C
author_sort Lenoir-Wijnkoop, I
collection OXFORD
description INTRODUCTION: Antibiotic-associated diarrhea (AAD) is common and frequently more severe in hospitalized elderly adults. It can lead to increased use of healthcare resources. We estimated the cost-effectiveness of a fermented milk (FM) with probiotic in preventing AAD and in particular Clostridium difficile-associated diarrhea (CDAD). METHODS: Clinical effectiveness data and cost information were incorporated in a model to estimate the cost impact of administering a FM containing the probiotic Lactobacillus paracasei ssp paracasei CNCM I-1518 in a hospital setting. Preventing AAD by the consumption of the probiotic was compared to no preventive strategy. RESULTS: The probiotic intervention to prevent AAD generated estimated mean cost savings of £339 per hospitalized patient over the age of 65 years and treated with antibiotics, compared to no preventive probiotic. Estimated cost savings were sensitive to variation in the incidence of AAD, and to the proportion of patients who develop non-severe/severe AAD. However, probiotics remained cost saving in all sensitivity analyses. CONCLUSION: Use of the fermented dairy drink containing the probiotic L. paracasei CNCM I-1518 to prevent AAD in older hospitalized patients treated with antibiotics could lead to substantial cost savings.
first_indexed 2024-03-06T23:37:08Z
format Journal article
id oxford-uuid:6e093f59-0102-4ded-a2dc-8d8da5f4891f
institution University of Oxford
language English
last_indexed 2024-03-06T23:37:08Z
publishDate 2014
publisher Frontiers Media
record_format dspace
spelling oxford-uuid:6e093f59-0102-4ded-a2dc-8d8da5f4891f2022-03-26T19:21:48ZNutrition economic evaluation of a probiotic in the prevention of antibiotic-associated diarrheaJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6e093f59-0102-4ded-a2dc-8d8da5f4891fEnglishSymplectic Elements at OxfordFrontiers Media2014Lenoir-Wijnkoop, INuijten, MCraig, JButler, CINTRODUCTION: Antibiotic-associated diarrhea (AAD) is common and frequently more severe in hospitalized elderly adults. It can lead to increased use of healthcare resources. We estimated the cost-effectiveness of a fermented milk (FM) with probiotic in preventing AAD and in particular Clostridium difficile-associated diarrhea (CDAD). METHODS: Clinical effectiveness data and cost information were incorporated in a model to estimate the cost impact of administering a FM containing the probiotic Lactobacillus paracasei ssp paracasei CNCM I-1518 in a hospital setting. Preventing AAD by the consumption of the probiotic was compared to no preventive strategy. RESULTS: The probiotic intervention to prevent AAD generated estimated mean cost savings of £339 per hospitalized patient over the age of 65 years and treated with antibiotics, compared to no preventive probiotic. Estimated cost savings were sensitive to variation in the incidence of AAD, and to the proportion of patients who develop non-severe/severe AAD. However, probiotics remained cost saving in all sensitivity analyses. CONCLUSION: Use of the fermented dairy drink containing the probiotic L. paracasei CNCM I-1518 to prevent AAD in older hospitalized patients treated with antibiotics could lead to substantial cost savings.
spellingShingle Lenoir-Wijnkoop, I
Nuijten, M
Craig, J
Butler, C
Nutrition economic evaluation of a probiotic in the prevention of antibiotic-associated diarrhea
title Nutrition economic evaluation of a probiotic in the prevention of antibiotic-associated diarrhea
title_full Nutrition economic evaluation of a probiotic in the prevention of antibiotic-associated diarrhea
title_fullStr Nutrition economic evaluation of a probiotic in the prevention of antibiotic-associated diarrhea
title_full_unstemmed Nutrition economic evaluation of a probiotic in the prevention of antibiotic-associated diarrhea
title_short Nutrition economic evaluation of a probiotic in the prevention of antibiotic-associated diarrhea
title_sort nutrition economic evaluation of a probiotic in the prevention of antibiotic associated diarrhea
work_keys_str_mv AT lenoirwijnkoopi nutritioneconomicevaluationofaprobioticinthepreventionofantibioticassociateddiarrhea
AT nuijtenm nutritioneconomicevaluationofaprobioticinthepreventionofantibioticassociateddiarrhea
AT craigj nutritioneconomicevaluationofaprobioticinthepreventionofantibioticassociateddiarrhea
AT butlerc nutritioneconomicevaluationofaprobioticinthepreventionofantibioticassociateddiarrhea